Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)news2024-05-15T13:02:51+00:00May 15th, 2024|Medical Device News Magazine|
AbbVie and Gilgamesh Pharmaceuticals | Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disordersnews2024-05-13T15:03:07+00:00May 13th, 2024|Medical Device News Magazine|
PharmaLogic Announces Opening of Radiopharmaceutical Production Facility in New York Citynews2024-05-13T15:00:01+00:00May 13th, 2024|Medical Device News Magazine|
Ossium Health Launches HOPE Program to Give All Patients Hope for a Curenews2024-05-10T19:10:58+00:00May 10th, 2024|Medical Device News Magazine|
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatmentsnews2024-05-06T19:45:05+00:00May 6th, 2024|Medical Device News Magazine|
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessmentnews2024-05-02T16:19:59+00:00May 2nd, 2024|Medical Device News Magazine|
Unleashing Biotech Potential: ATLATL Scientific & Miltenyi Biotec Partnershipnews2024-04-30T18:11:04+00:00April 30th, 2024|Medical Device News Magazine|
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancernews2024-04-25T10:37:06+00:00April 25th, 2024|Medical Device News Magazine|
Lonza and Oxford Nanopore to Collaborate on Novel Test to Accelerate Analysis of mRNA Productsnews2024-01-30T15:00:34+00:00January 30th, 2024|Medical Device News Magazine|
AtlasXomics and EpiCypher Partnership | To Commercialize Spatial Epigenomics Assaysnews2024-01-23T17:54:14+00:00January 23rd, 2024|Medical Device News Magazine|
